西比灵联合头痛宁胶囊治疗偏头痛的临床效果观察

摘要

Objective To investigate sibelium joint Toutongning capsule treatment of migraine headache clinical observation. Methods Clinical data randomly selected 84 cases of patients with migraine hospital in May 2010-June 2011 a total of diagnosis and treatment were randomly divided into two groups, with each study group, 42 cases in which the West than the control group Toutongning capsule treatment, research group sibelium joint capsule headache treatment. Results The study group patients after clinical treatment, the effective rate was 95.24%, significantly higher than the efficiency of 76.19%, the clinical statistical analysis, there was a significant difference (P<0.05). Conclusion Sibelium joint Toutongning capsule treatment of migraine headache patients, the clinical effect is significant, no adverse reactions, safe and effective, it is worth the long-term clinical application.%目的：探讨西比灵联合头痛宁胶囊治疗偏头痛的临床效果观察。方法随机抽取本院2010年5月至2011年6月共诊治的84例偏头痛患者的临床资料，将其随机分为两组，对照组与研究组各42例，其中对照组采用西比灵胶囊治疗，研究组西比灵联合头痛宁胶囊治疗。结果研究组患者经临床治疗后，有效率为95.24%，明显高于对照组有效率76.19%，经临床统计学分析，有显著统计学差异（P＜0.05）。结论西比灵联合头痛宁胶囊治疗偏头痛患者，其临床疗效显著，无不良反应，安全有效，值得临床长期推广应用。